Clinical Trial Update: Dose-Finding Study of SC411 in Children With Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of SC411 is being conducted in children with sickle cell disease; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• SC411

Snippet

Sponsor: Micelle BioPharma Inc | Conditions: Sickle Cell Disease | Phase 2 | Status: UNKNOWN